DrMohammad Bakhriansyah

Mohammad Bakhriansyah earned his medical doctor at School of Medicine, Universitas Lambung Mangkurat, Banjarmasin, Indonesia. He continued his master education in the Basic and Biomedical Sciences with a specialization in pharmacology. His thesis is about herbal medicine for breast cancer from bio-molecular perspectives. Thus, he was extensively exposed to cyclooxygenase enzymes as a treatment target. Later on, non-steroidal anti-inflammatory drugs that inhibit these enzymes become his interest for his Ph.D. projects. Since he realized he should improve his didactical skills, he took a master program in medical education. By the end of 2019, he finished his doctoral degree at the Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, the Netherlands. His thesis is titled “SAFETY PROFILE OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN CLINICAL PRACTICE: New Insights from Electronic Health Care and Spontaneous Reporting Databases“ During his Ph.D. internship, he was granted a master degree in epidemiology with a specialization in pharmacoepidemiology from the Julius Center, University Medical Center, Utrecht University.